Sightline Innovation congratulates Canada's National Microbiology Lab on Ebola vaccine

August 6, 2015

Sightline Innovation Inc. wishes to congratulate Dr. Frank Plummer and the scientists that worked at the National Microbiology Laboratory (NML) to develop the Ebola vaccine (VSV-Vaccine), that is showing highly promising results from the trial in Guinea. This 15 year collaboration demonstrates the importance of a long-term vision for infectious disease management, and their focus on scientific excellence.

Click here for the article.

Share This Story


"Sightline moved to Manitoba to contribute to the community of scientific excellence fostered by the National Microbiology Lab, and the Universities of Winnipeg and Manitoba. This announcement reinforces that we made the right decision and intensifies our support because to flourish in such a highly competitive space, you need to be working amid the best minds in the world", said Wallace Trenholm, Founder & CEO, who also added that "Winnipeg's scientists and those that built the team are second to none."